This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Thomas J J Müller: Innovator in Kinetoplastideae Parasite Research
Introduction
Thomas J J Müller is a distinguished inventor based in Düsseldorf, Germany. He has made significant contributions to the field of parasitology, particularly in the development of compounds aimed at combating kinetoplastideae parasites. His innovative work has the potential to impact the treatment and prevention of serious diseases such as trypanosomiasis and leishmaniasis.
Latest Patents
Müller's most notable patent is titled "Compounds useful against kinetoplastideae parasites - Dibenzylidene and heterobenzylideneacetone derivatives, related 4-piperidones, related 4-thiopyranones and the corresponding sulfinyl- and sulfonyl-analogues for their use for prophylaxis or treatment of trypanosomiasis and leishmaniasis." This patent highlights his focus on creating effective therapeutic agents against these challenging diseases. He holds 1 patent in this area.
Career Highlights
Müller is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research. His work is characterized by a commitment to addressing critical health issues through innovative scientific solutions. His research has garnered attention for its potential applications in medicine and public health.
Collaborations
Müller has collaborated with esteemed colleagues, including Elisabeth Davioud-Charvet and Ingrid Nicole Wenzel. These partnerships have enriched his research and contributed to the advancement of knowledge in the field of parasitology.
Conclusion
Thomas J J Müller is a prominent figure in the fight against kinetoplastideae parasites, with a focus on developing innovative compounds for treatment and prevention. His contributions to science and medicine are invaluable, and his work continues to inspire future research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
